These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27481041)

  • 1. The skin in autoimmune diseases-Unmet needs.
    Kuhn A; Landmann A; Bonsmann G
    Autoimmun Rev; 2016 Oct; 15(10):948-54. PubMed ID: 27481041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease.
    Streicher K; Sridhar S; Kuziora M; Morehouse CA; Higgs BW; Sebastian Y; Groves CJ; Pilataxi F; Brohawn PZ; Herbst R; Ranade K
    Arthritis Rheumatol; 2018 Dec; 70(12):2087-2095. PubMed ID: 29956883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Pruritus in Autoimmune Connective Tissue Diseases.
    Yahya A; Gideon P. S
    J Drugs Dermatol; 2019 Oct; 18(10):995-998. PubMed ID: 31584777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
    Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
    Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood systemic lupus erythematosus, dermatomyositis, scleroderma, and systemic vasculitis.
    Ilowite NT
    Curr Opin Rheumatol; 1993 Sep; 5(5):644-50. PubMed ID: 8104454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
    Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
    Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositis.
    Zhang Y; Maskan Bermudez N; Sa B; Maderal AD; Jimenez JJ
    Exp Dermatol; 2024 Jan; 33(1):e14986. PubMed ID: 38059632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous signs of classical dermatomyositis.
    Auriemma M; Capo A; Meogrossi G; Amerio P
    G Ital Dermatol Venereol; 2014 Oct; 149(5):505-17. PubMed ID: 25014587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
    Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients.
    Chanprapaph K; Limtong P; Ngamjanyaporn P; Suchonwanit P
    Dermatology; 2022; 238(4):677-687. PubMed ID: 34879369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.
    Lei W; Luo Y; Lei W; Luo Y; Yan K; Zhao S; Li Y; Qiu X; Zhou Y; Long H; Zhao M; Liang Y; Su Y; Lu Q
    Scand J Rheumatol; 2009; 38(5):369-74. PubMed ID: 19444718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus exacerbation following cessation of belimumab treatment.
    Furer V; Zisman D; Pokroy-Shapira E; Molad Y; Elkayam O; Paran D
    Scand J Rheumatol; 2016; 45(2):103-6. PubMed ID: 26515057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic manifestations of skin disease.
    Clarke JT; Werth VP
    Curr Opin Rheumatol; 2010 Jan; 22(1):78-84. PubMed ID: 19851110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-threatening dermatoses due to connective tissue disorders.
    Katsambas A; Stefanaki C
    Clin Dermatol; 2005; 23(3):238-48. PubMed ID: 15896538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.